| Identification | |
| Name: | Phenanthro[1,2-b]furan-10,11-dione,1,2,6,7,8,9-hexahydro-1,6,6-trimethyl-, (1R)- |
| Synonyms: | (R)-1,2,6,7,8,9-Hexahydro-1,6,6-trimethyl-phenanthro(1,2-b)furan-10,11-dione |
| CAS: | 35825-57-1 |
| Molecular Formula: | C19H20O3 |
| Molecular Weight: | 296.36 |
| InChI: | InChI=1/C19H20O3/c1-10-9-22-18-12-6-7-13-11(5-4-8-19(13,2)3)15(12)17(21)16(20)14(10)18/h6-7,10H,4-5,8-9H2,1-3H3/t10-/m0/s1 |
| Molecular Structure: |  |
| Properties | |
| Melting Point: | 184 ºC ~ 185ºC |
| Density: | 1.23 g/cm3 |
| Refractive index: | 1.602 |
| Appearance: | orange needle crystal |
| Specification: |
?Cryptotanshinone with cas registry number of 35825-57-1 is also known as (R)-1,2,6,7,8,9-hexahydro-1,6,6-trimethyl-phenanthro(1,2-b)furan-10,11-dione ; Tanshinone,crypto ; 98% BY HPLC ; Cryptotanshinone> ; Tanshinone,crypto(P) ; Hexahydro-1,6,6-trimethyl-,(R)- ; Phenanthro[1,2-b]furan-10,11-dione,1,2,6,7,8,9- . It is an aromatic annulation strategy with the appearance of orange needle-like crystals. It is slightly soluble in Ethanol , Methanol , Benzene and other related organic solvents. Cryptotanshinone is used as a useful medicine. It has the anti-oxidation, anti-aging function and It has a certain effect in the treatment of coronary heart disease, angina pectoris, myocardial damage. |
| Safety Data | |
 |
|
